Financials HBM Healthcare Investments AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:30 2025-01-23 am EST			5-day change	1st Jan Change
192.00 ^CHF	+0.95%		+6.67%	+9.09%

Jan. 20	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
Jan. 20	Swiss Stocks Close Higher; All Eyes on Trump's Inauguration Day	MT

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	-	-	-37.5	-116.5	23.79	76.9	132.3	134.4
Change	-	-	-	210.8%	-	223.26%	72.04%	1.59%
EBITDA ¹	185.1	758.7	-75.31	-146.1	-2.574	51.7	107.1	109.3
Change	-	309.84%	-	93.97%	-98.24%	-	107.16%	2.05%
EBIT ¹	185.1	758.7	-75.31	-146.1	-2.574	51.7	107.1	109.3
Change	-	309.84%	-	93.97%	-98.24%	-	107.16%	2.05%
Interest Paid	-	-	-	-	2.087	-	-	-
Earnings before Tax (EBT) ¹	182.7	756.3	-78.03	-145.3	-0.487	51.7	107.1	109.3
Change	-	313.95%	-	86.2%	-99.66%	-	107.16%	2.05%
Net income ¹	183	756.3	-78.03	-145.3	-0.487	51.7	107.1	109.3
Change	-	313.26%	-	86.2%	-99.66%	-	107.16%	2.05%
Announcement Date	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-	-

¹CHF in Million

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-	96.2	144	143	89.2	-117	-127	-141
Change	-	-	49.69%	-0.69%	-37.62%	-231.22%	-208.55%	-211.02%
Announcement Date	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-	-

¹CHF in Million

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Free Cash Flow (FCF) ¹	-64.16	55.77	-60.2	89.12	92.86	64.9	64.9	69.9
Change	-	-186.93%	-207.93%	-248.06%	4.19%	-30.11%	0%	7.7%
Announcement Date	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-	-

¹CHF in Million

Estimates

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	200.85%	125.35%	-10.82%	67.23%	80.95%	81.32%
EBIT Margin (%)	-	-	-	200.85%	125.35%	-10.82%	67.23%	80.95%	81.32%
EBT Margin (%)	-	-	-	208.1%	124.67%	-2.05%	67.23%	80.95%	81.32%
Net margin (%)	-	-	-	208.1%	124.67%	-2.05%	67.23%	80.95%	81.32%
FCF margin (%)	-	-	-	160.54%	-76.48%	390.33%	84.4%	49.06%	52.01%
FCF / Net Income (%)	-	-35.06%	7.37%	77.14%	-61.34%	-19,066.94%	125.53%	60.6%	63.95%
Profitability
ROA	9.86%	7.78%	24.87%	-2.14%	-4.42%	0.02%	-	-	-
ROE	16.89%	13.21%	42.01%	-3.77%	-7.78%	-0.06%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	0.13x	-1.91x	-0.98x	-34.64x	-	-	-
Debt / Free cash flow	-	-	1.72x	-2.38x	1.61x	0.96x	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	7.7	12.5	9.7	7.5	7.5	7.19	7.79	7.79
Change	-	-	62.34%	-22.4%	-22.68%	0%	-4.13%	8.34%	0%
Book Value Per Share ¹	-	188	309.2	285.5	255	248.1	245.4	252.9	260.7
Change	-	-	64.49%	-7.67%	-10.69%	-2.71%	-1.07%	3.04%	3.08%
EPS ¹	-	26.26	108.7	-11.22	-20.98	-0.07	7.24	15.29	15.6
Change	-	-	313.98%	-110.32%	86.99%	-99.67%	-10,442.86%	111.19%	2.03%
Nbr of stocks (in thousands)	-	6,947	6,957	6,957	6,957	6,911	6,772	6,772	6,772
Announcement Date	-	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-	-